The focus of this research was to develop a better understanding of the pertinent physico-chemical properties of silver nanoparticles (AgNPs) that affect genotoxicity, specifically how cellular uptake influences a genotoxic cell response. The genotoxicity of AgNPs was assessed for three potential mechanisms: mutagenicity, clastogenicity and DNA strand-break-based DNA damage. Mutagenicity (reverse mutation assay) was assessed in five bacterial strains of Salmonella typhimurium and Echerichia coli, including TA102 that is sensitive to oxidative DNA damage. AgNPs of all sizes tested (10, 20, 50 and 100 nm), along with silver nitrate (AgNO 3 ), were negative for mutagenicity in bacteria. No AgNPs could be identified within the bacteria cells using transmission electron microscopy (TEM), indicating these bacteria lack the ability to actively uptake AgNPs 10 nm or larger. Clastogenicity (flow cytometry-based micronucleus assay) and intermediate DNA damage (DNA strand breaks as measured in the Comet assay) were assessed in two mammalian white blood cell lines: Jurkat Clone E6-1 and THP-1. It was observed that micronucleus and Comet assay end points were inversely correlated with AgNP size, with smaller NPs inducing a more genotoxic response. TEM results indicated that AgNPs were confined within intracellular vesicles of mammalian cells and did not penetrate the nucleus. The genotoxicity test results and the effect of AgNO 3 controls suggest that silver ions may be the primary, and perhaps only, cause of genotoxicity. Furthermore, since AgNO 3 was not mutagenic in the gram-negative bacterial Ames strains tested, the lack of bacterial uptake of the AgNPs may not be the major reason for the lack of genotoxicity observed.
Introduction
Silver (Ag), in the form of colloidal silver, has been historically consumed as an antimicrobial substance. Like some other non-traditional antibiotics, ionic silver (Ag + ) is effective in more environments than traditional antibiotics because they interact/interfere with multiple components of bacterial cell functions. Due to strong electrostatic interaction between silver ions and the internal electron donor groups of proteins, such as thiols, silver ions are able to interfere with and/or inactivate key bacterial proteins (1, 2) . Similarly, past work indicates that silver ions competitively bind to metal chelation sites within enzymes, thereby displacing the inherent metal cation necessary for proper functioning (3) . Such enzyme interference/inactivation directly impacts various critical cellular functions including cellular respiration and oxidation (4, 5) , cell wall integrity (6) and cell transport/permeability (7) . Moreover, silver ions have been shown to inhibit cellular replication by inducing the condensation of DNA (1) and to directly interact with the bases of various bacterial nucleic acids (8) . Silver ions have also been implicated in the generation and accumulation of reactive oxygen species within bacteria, which can result in damage to cellular components, including chromatin, thus disrupting critical cell functions (9) . Although ionic silver has demonstrated antimicrobial properties, it has also demonstrated toxicity to animals and humans. Toxicity is dependent on the state of the silver: metallic, soluble or insoluble. Repeat exposure to ionic silver has been shown to produce anaemia, cardiac enlargement, growth retardation and degenerative changes in the liver in animals (10, 11) . Chronic exposure in humans most commonly leads to argyria, which is an irreversible blue-gray pigmentation of the skin and/or eyes (12) .
There has been a tremendous increase in the application of silver nanoparticles (AgNPs) as antimicrobial agents. AgNPs are the most commonly used nanomaterial in consumer products (13) and are used in many medical products including dental resin composites (14) , catheters (15) (16) (17) (18) (19) , wound dressings (20) and surgical masks (21) . One major benefit of nanoparticulate silver over ionic silver is the rate at which silver ions, the active antibacterial agent, are released. With ionic silver, there is typically an instant or bolus release of silver ions upon interaction with an aqueous medium. In contrast, the release of silver ions from nanoparticulate silver is dependent on the oxidation of the metallic silver (Ag 0 ) within the particle. The oxidation and subsequent release of silver ions is dependent on various physico-chemical properties of the particle including particle size (22) (23) (24) , shape (25) , surface coating (26) and solubility (24, 26, 27) . Since one is able to alter ion release by varying the physico-chemical properties of the particle, nanoparticulate silver is thought to offer a tunable method for the delivery of silver ions. As such, it has been difficult to determine which nanoscale physico-chemical properties influence antimicrobial activity the most and, more specifically, whether the particle itself has any microbial toxicity or whether this toxicity is due only to released silver ions. Due to the public's increased exposure through various consumer and medical products, it is important that the scientific and regulatory community gain a better understanding of the antimicrobial efficacy and toxicity of AgNPs.
Two areas of particular concern in AgNP exposure are cytotoxicity and genotoxicity. High concentrations of AgNPs have been shown to induce genotoxicity and to reduce the viability of various cell types (10, 28, 29) . Previous research has shown that both the cytotoxic and genotoxic effects of AgNPs, as well as their interaction with cells, are dependent on both size (30, 31) and chemical coating (30, 32, 33) . AgNP exposure can occur through dermal contact, oral administration, inhalation, contact with mucosal membranes and/ or blood circulation. Research has shown that the route of exposure drastically influences toxicity outcomes (34) (35) (36) . It has also been demonstrated that the toxicity response varies depending on cell type or tissue (31, 33, 36, 37) . Furthermore, the mechanism of toxicity or cell damage can be different across various cell types, suggesting that the cell selected can have a profound impact on the outcome of a particular study.
It is important to determine the features of the AgNPs that lead to mammalian cell toxicity. As an initial step towards understanding the effects of size, four diverse sizes of AgNPs, all capped with the same molecule, were examined for cytotoxicity, genotoxicity and cellular interaction in both bacterial and mammalian cells. For the latter, we chose human monocytes and T cells, as these cells could be exposed by blood contact with AgNPs. We chose to work with cell lines to reduce variability that can be found in donor human peripheral blood lymphocytes. Monocytes were selected due to their phagocytic capacity, which could be important in cell to NP interactions. CD3-positive T cells were selected as they are the most prevalent white blood cell in human blood. In addition, CD3-positive T cells have been shown to interact differently with polyvinylpyrrolidone (PVP)-coated AgNPs (38) . To examine genotoxicity, we used assays covering mutations, chromosomal damage and DNA strand breakage. Bacterial mutation assays detect damage encompassing a few nucleotides such as point mutations and small deletions, while the micronucleus assay measures chromosomal damage as fragments; the Comet assay measures DNA strand breaks, an intermediate for many types of DNA damage. This research provides a comprehensive study attempting to correlate AgNP size, cellular interaction/uptake and corresponding cytotoxicity and genotoxicity.
Materials and Methods

Materials
Bacterial strains
Bacterial strains Salmonella typhimurium (S.typhimurium) TA100, TA98, TA102 and Escherichia coli (E.coli) WP2 pKM101 and WP2 uvrA pKM101 were obtained from MolTox (Boone, NC, USA).
Chemicals and reagents
AgNPs of four diameters (10, 20, 50 and 100 nm), suspended at 1 mg/ml in 2 mM sodium citrate buffer, as well as additional 2 mM sodium citrate buffer (neat) were purchased from nanoComposix (San Diego, CA, USA). As the first batch of NPs (Batch 1) was exhausted in the general toxicity and genotoxicity experiments, a second batch (Batch 2) was purchased and characterised for use in all DNA repair and uptake experiments. Purchasing two batches also ensured particles were non-agglomerated and representative of their stated size throughout their respective experiments.
Mutagens ethyl methanesulfonate (EMS), 2-Nitrofluorene (2-NF) and tert-Butyl hydroperoxide solution 70% wt in water (tB), along with Medium E salts (sodium ammonium hydrogen phosphate, etc.) and glucose, were also obtained from Sigma-Aldrich (St Louis, MO, USA).
AgNO 3 (American Chemical Society reagent grade, 99.9% purity), ethanol (200 proof/100%, molecular biology grade) and tissue culture double-processed water (sterile filtered, endotoxin tested) were purchased from Sigma-Aldrich.
Experimental supplies
Difco® nutrient broth, Difco® nutrient agar, Sarstedt® polystyrene cuvettes (10 × 10 × 45 mm), Malvern® folded capillary cells, Corning® 96-well plates, Corning® cell culture flasks (untreated, 25 cm 2 , vented cap) and NUNC® CryoTubes™ (1 ml, internal thread, polypropylene) were purchased from Fisher Scientific (Hampton, NH, USA). Oxoid Nutrient Broth (from Oxoid Ltd, Basingstoke, Hampshire, UK) was purchased from Fisher Scientific. Luria Broth was purchased from Gibco BRL (Grand Island, NY, USA).
Micronucleus assay
Roswell Park Memorial Institute (RPMI-1640), fetal bovine serum, dimethyl sulfoxide and Dulbecco's phosphate-buffered saline (PBS) were purchased from ATCC (Manassas, VA, USA). Additionally, 2-mercaptoethanol was purchased from Sigma-Aldrich. Corning® 24-well plates, Corning® cell culture flasks (untreated, 75 cm Transmission electron microscopy Support film grids (carbon type B, 300 mesh, copper) for transmission electron microscopy (TEM) were purchased from Ted Pella Inc. (Redding, CA, USA). Glutaraldehyde (2.5% in 0.1 M sodium cacodylate buffer pH 7.4), sodium cacodylate buffer (0.2 M, pH 7.4), propylene oxide (99.5%, reagent grade), osmium tetroxide (OsO 4 ) (2% aqueous solution), LX112 (EMBED-812), dodecenyl succinic anhydride (DDSA) (95%, 98-98% anhydride), methyl-5-norbornene-2,3-dicarboxylic anhydride (NMA) (99%, 98-99% anhydride) and 2,4,6-9-tri(dimethylaminoethyl)phenol (DMP-30) (>85%) were all purchased from Electron Microscopy Sciences (Hatfield, PA, USA). Deionised (DI) water was obtained using a Thermo Scientific Barnstead Nanopure Diamond ultrapure water purification system. It should be noted that a Getinge (Rochester, NY, USA) Castle Model 533LS autoclave was used for sterilising reagents, buffers, water etc. used in these experiments.
Methods
Characterisation of AgNPs
The AgNPs were analysed using dynamic light scattering (DLS; Malvern Zetasizer Nano ZS), zeta potential analysis (Malvern Zetasizer Nano ZS), NP tracking analysis (NTA; NanoSight NS500), ultraviolet/visible light (UV/Vis) spectroscopy (Molecular Devices SpectraMAX 190) and TEM (JEOL JEM-1011) in order to determine size distribution and agglomeration of the particles. For DLS and zeta potential analysis, all particles were diluted to appropriate concentrations for measurement with double-processed tissue culture grade water. Each solution was thoroughly mixed before measurement. For DLS, 2 ml of the mixed solution was then placed into disposable polystyrene cuvettes and analysed accordingly with a Malvern Zetasizer Nano ZS (Malvern, Worcestershire, UK). For zeta potential analysis, ~1 ml of mixed solution was added to a disposable folded capillary cell, which was then analysed with a Malvern Zetasizer Nano ZS. For NTA, 1 ml of the mixed solution was added to a polystyrene cuvette and analysed with a Nanosight NS500. The 10 nm NPs were not analysed using NTA since this technique cannot resolve particle sizes below 15 nm.
For UV/Vis spectroscopy 5 µl of stock NP solution was thoroughly mixed into 95 µl of double-processed tissue culture water in triplicate for each particle size in a 96-well polystyrene plate. The light absorbance of each solution was then measured using a Molecular Devices (Sunnyvale, CA, USA) Spectra MAX 190 for wavelengths ranging from 350 to 750 nm in 1-nm increments.
For TEM, 5 µl of each stock solution (10, 20, 50 and 100 nm diameter particles) were placed on a carbon-based support grid (carbon type B, mesh 300, copper) and imaged with a JEOL (Peabody, MA, USA) JEM-1400 transmission electron microscope operated at 80 kV. The image processing program ImageJ (National Institutes of Health) was utilised to measure at least 200 particles from each stock solution to determine particle size distributions. For energy dispersive x-ray spectroscopy (EDS) analysis, a scanning transmission electron microscopy micrograph was obtained using a JEOL-1400 transmission electron microscope. Specific points within the image were analysed using an Oxford Instruments (Oxfordshire, UK) X-Max N 80 T with corresponding INCA software.
Bacterial culture
Salmonella typhimurium strains TA100, TA98 and TA102 were grown from fresh frozen stock overnight to stationary phase in Oxoid nutrient broth at 37°C while shaking. Escherichia coli strains WP2 and WP2 uvrA were grown to stationary phase from fresh frozen stock overnight in Luria broth at 37°C while shaking. Culture growth was assessed by absorbance (optical density, OD) at 600 nm using a ThermoScientific (Waltham, MA, USA) GENESYS 20 visible spectrophotometer. All cultures were above an OD of 1.0 at 600 nm (OD 600 nm ) at time of experimental use.
Antimicrobial experiments with gram-negative S.typhimurium and E.coli tester strains A preliminary experiment was conducted on three strains of bacteria (E.coli WP2 uvrA, S.typhimurium TA100 ΔuvrB and S.typhimurium TA102 uvr + ) to determine the concentration and size-dependent limits of AgNP antimicrobial efficacy. Seven compounds were tested at six different concentrations for inhibitory effects with these bacterial strains. The test compounds included 10, 20, 50 and 100 nm AgNPs, AgNO 3 at 1 mg/ml DI water (positive control), 2 mM sodium citrate buffer (negative control) and autoclave-sterilised DI water (negative control). Bacterial cultures were incubated overnight (under agitation) in nutrient broth at 37°C to stationary phase. After determining the dilution scheme necessary to achieve an OD 600 nm ~ 0.28 ± 0.02, indicating a concentration of ~10 8 colony forming unit (CFU)/ml, an appropriate amount of bacteria was added to 5 ml of nutrient broth and then further diluted 1000× in DI water to make 200 ml of bacterial solution at 10 5 CFU/ml. Diluted test compound (100 µl) was added to 9.9 ml of bacterial solution in a vented culture flask to yield a final test compound concentration of 0.1, 1, 10, 100, 500 or 1000 ng/ml with 10 5 bacterial CFU/ml. The flasks were then gently agitated at 60 r.p.m. at 37°C for 1 h. After this pre-incubation, two sets of serial 100-fold dilutions of the bacterial cultures were made (100 µl of culture mixed with 9.9 ml of water). Each dilution (250 µl) was plated in triplicate on nutrient agar, allowed to dry, covered and incubated at 37°C for 24 h (for E.coli uvrA), 48 h (for TA100) or 72 h (for TA102). Following incubation, colonies were counted by hand (less than ~200 CFUs) or with a Synbiosis (Frederick, MD, USA) ProtoCOL 3 automatic colony counter (greater than ~200 CFUs) to determine bacterial viability. Dilutions with countable colony numbers were used for the survival calculations.
Values for triplicate plates within each dilution were averaged. The log reduction factor was determined by dividing the colonies for the control by the colonies observed in the sample and taking the respective log. For the 'zero' dilution, e.g. sample taken straight from the test flask, the control samples often consisted of >2500 CFUs and were unable to be read accurately by the colony counter. In these cases, the counts from the 100-fold dilution were used. The colony count obtained for the 100-fold (10 −2 ) dilution was multiplied by 100 to obtain an estimate colony count for the 10 0 dilution. The reduction factor obtained for each dilution was averaged to get the final reduction factor reported in Supplementary Table 1, available at Mutagenesis Online.
Bacterial reverse mutation assay with pre-incubation For pre-incubation, 100 µl aliquots of overnight bacterial cultures were dispensed to 96-well microtiter plates. Ten-microlitre volumes of vehicle, positive controls or AgNPs were incubated with bacteria for 60 min at 37°C with shaking. Positive controls used were EMS, 2-NF and tB. After incubation, the contents of each well were plated with 2 ml top agar (plus histidine and biotin for Salmonella strains or with tryptophan for E.coli) on minimal Medium E plates (39) . After incubation for 48 h, revertant colonies were counted using a Synbiosis Protocol 3 colony counter. Samples were tested in triplicate.
Bacterial DNA repair assay A method for assessment of DNA repair capability via 'liquid holding' has been developed in this laboratory (unpublished). The classical discovery of DNA repair involved the measurement of enhanced survival of UV-irradiated bacteria as a function of 'holding time' before plating for measurement of survival. In the adapted protocol used here, the bacteria are irradiated with UV and held for up to 60 min prior to plating, to allow DNA repair. When DNA repair occurs (only in repair competent bacteria), the mutant yield is observed to decline as a function of holding time. NPs are added post-UV during the DNA repair phase, to assess the effect on DNA repair. For the DNA repair experiments, 100 µl aliquots of uvr+ bacterial cultures TA102 and WP2 pKM101 (both uvr + ) were placed in a 96-well plate and exposed to ultraviolet C radiation for times varying from 0 to 30 s (1 s = 100 µJ/cm 2 ). UV radiation was provided by a Spectronics Corporation (Westbury, NY, USA) SpectroLinker XL-1500 UV Crosslinker. After UV exposure, 10 µl volumes of vehicle controls, AgNO 3 or AgNPs were added (500 µg/plate). After NP addition, bacterial cells were incubated for 60 min at room temperature in the dark to allow DNA repair. After incubation, the contents of each well were plated with top agar plus histidine and biotin (TA102) or tryptophan (WP2pKM101) on minimal Medium E plates (39) . After incubation for 48 h, revertant colonies were counted using a Synbiosis ProtoCOL 3 colony counter. Samples were tested in triplicate.
TEM for uptake experiment
Bacteria were incubated with AgNPs (5 µg/ml) for 60 min after which cultures were spun down and embedded in low-melting point agarose, fixed and sliced into 80 nm thick sections for TEM analysis.
Cells (1 × 10 6 ) of each mammalian cell line were exposed to 25 µg/ml AgNPs for 24 h. After exposure, the cells were pelleted in a 1.5-ml polypropylene microcentrifuge tube. The media was aspirated from the pellets and the pellets were embedded in low-melting point agarose prior to fixing and sectioning the pellets for TEM.
Each cell pellet was placed inside a 1.5 ml polypropylene microcentrifuge tube. Approximately 1 ml of a fixative solution, consisting of 2.5% glutaraldehyde in 0.1 M cacodylate buffer, was added to each pellet. The tubes were then allowed to stand overnight to ensure adequate fixation. After fixation, the pellets were dehydrated using a Leica Microsystems (Buffalo Grove, IL, USA) EM TP tissue processor using the following conditions: 3 × 0.1 M cacodylate buffer for 10 min; 1 × 1% osmium tetroxide in 0.1 M cacodylate buffer for 60 min; 2 × 0.1 M cacodylate buffer for 10 min; 3 × 0.1 M acetate buffer for 10 min; 2 × 35% ethanol for 10 min; 2 × 50% ethanol for 10 min; 2 × 70% ethanol for 10 min; 2 × 95% ethanol for 10 min; 3 × 100% ethanol for 10 min; 3 × propylene oxide for 20 min and 50% epoxy resin and 50% propylene oxide for 12 h. The epoxy resin consisted of 5.35 g LX112 (EMBED-812), 2.05 g DDSA, 2.6 g NMA and 0.14 ml DMP-30. All vials contained 10 ml of their respective solution. For solutions of propylene oxide, 13 ml was added to the vial due to its high volatility.
After the dehydration process, the pellets were removed from the last processing vial and placed into a clean vial. A small amount of fresh resin [5.35 g LX112 (EMBED-812), 2.05 g DDSA, 2.6 g NMA, 0.14 ml DMP-30] was added to each pellet and the pellets were then placed in an oven (55°C) for 48 h. After 48 h, 80 nm sections of the sample were cut using a Leica UC7 ultramicrotome equipped with a glass knife (produced using a Leica EM KMR2 glass cutter). The 80 nm sections were transferred to support grids (carbon type B, 300 mesh, copper) and imaged with a JEOL JEM-1400 transmission electron microscope at an operating voltage of 80 kV. For EDS analysis, a scanning transmission electron micrograph image was obtained using a JEOL JEM-1400 transmission electron microscope and specific points within the image were analysed using an Oxford Instruments X-Max N 80 T with corresponding INCA software. In each image, 'Spectrum 1' corresponds to the extracellular background composition, 'Spectrum 2' corresponds to the intracellular background composition and 'Spectrum 3' and 'Spectrum 4' correspond to the observed AgNPs (or the absence thereof in the negative controls).
Mammalian cell culture
Jurkat Clone E6-1 and THP-1 cell lines were purchased from ATCC (Manassas, VA, USA) and maintained in culture as recommended by ATCC. Standard Jurkat Clone E6-1 cell media consisted of RPMI-1640 with fetal bovine serum added to a final concentration of 10%.
Standard THP-1 cell media consisted of RPMI-1640 plus 2-mercaptoethanol to a final concentration of 0.05 mM and fetal bovine serum added to a final concentration of 10%.
Mammalian cell exposure to AgNPs
Cells (1 × 10 6 ) were plated per well in 24-well plates in standard media to which sodium citrate (vehicle control), 10, 20, 50, 100 nm AgNPs or AgNO 3 were added. AgNPs were prepared in water such that when added to cells in media, the final concentrations of AgNPs and AgNO 3 ranged from 0 to 50 µg/ml. Cells were exposed to AgNPs or AgNO 3 for 24 h at 37°C. After exposure, the samples were split for assessment of mitochondrial activity, micronucleus formation and DNA strand breaks as measured in the Comet (single cell gel electrophoresis) assay.
Mitochondrial activity assay
Mitochondrial activity of Jurkat and THP-1 cells was analysed using the CellTiter 96® AQ ueous Non-Radioactive Cell Proliferation Assay
is converted by cells, in the presence of phenazine methosulfate (PMS), to a formazan product that has an absorbance maximum at 490-500 nm and provides a method of assessing cell mitochondrial activity (MTS assay). Mammalian cell exposure to AgNPs was performed as described in Mammalian cell exposure to AgNPs. After 24 h exposure, 200 µl of each cell culture, corresponding to 2 × 10 5 cells, were washed in PBS by centrifugation and resuspended in fresh media to prevent the presence of the AgNPs from affecting the absorbance. Each 200 µl sample was diluted with fresh media to 1 ml; then 100 µl of each diluted sample were plated in a 96-well plate to which 20 µl of the MTS/phenazine methosulfate complete solution was added. The 96-well plates were kept at 37°C for 3 h. After 3 h, absorbance was read at 490 nm using a Tecan (Morrisville, NC, USA) Infinite M1000 Pro microplate reader. The mitochondrial activity was normalised to untreated negative controls. All samples were assessed in triplicate and experiments were done in duplicate.
Micronucleus assay
Micronucleus assay was performed as described for the High Content Protocol 1 in the instruction manual for the In Vitro MicroFlow® Kit (Litron Laboratories, Rochester, NY, USA) using reagents provided with the kit. Mammalian cell exposure to AgNPs was performed as described in Mammalian cell exposure to AgNPs. After 24 h exposure, 5 × 10 5 cells were removed from each culture and placed in 15 ml conical tubes. The conical tubes were centrifuged to collect the cells after which the cells were then resuspended in 100 µl PBS and transferred to a 96-well plate. The cells were processed and stained as described in the kit instruction manual and described briefly here. The cells were collected via centrifugation and the supernatant aspirated. Cell pellets were loosened by gentle tapping and the 96-well plate was placed on wet ice for 20 min. After 20 min, 50 µl of prepared Complete Nucleic Acid Dye A was added to each sample. The 96-well plate was then placed on wet ice and exposed to a visible light source as described in the kit protocol for 30 min. After 30 min, 150 µl of 1× buffer were added to each sample well. Cells were collected by centrifugation and supernatants were aspirated. Cell pellets were loosened by tapping and 100 µl of Complete Lysis Solution 1 was added to each sample. The 96-well plate was then incubated in the dark for 1 h at 37°C. After 1 h, 100 µl of Complete Lysis Solution 2 was added to each sample and the 96-well plate was incubated in the dark for 30 min prior to analysis. The samples were analysed using a BD Biosciences (San Jose, CA, USA) Fortessa flow cytometer. The stopping gate was set at 10 000 healthy nuclei, and the threshold and gating parameters were set as recommended in the instruction manual. All samples were assessed in triplicate and experiments were done in duplicate. Statistical analysis was performed by the t-test compared to untreated controls.
Comet assay
Mammalian cell exposure to AgNPs was performed as described in Mammalian cell exposure to AgNPs. After 24 h exposure, 1 × 10 5 cells were prepared to assess DNA damage. Hydrogen peroxide exposure for 1 h was used as a positive control. DNA damage was assessed using the alkaline Comet assay as described in the protocol for the Trevigen (Gaithersburg, MD, USA) Comet Assay Kit using reagents provided in the Comet assay kit. The methods are described briefly here. The 1 × 10 5 cells from each treatment were centrifuged and resuspended in 1 ml PBS. From this 1 ml of PBS, 10 µl was removed and added to 100 µl of agarose provided in the kit. From the agarose and cell mixture, 50 µl was spread on the kit provided Comet slides. Slides were allowed to gel for 30 min at 4°C in the dark. After gelling, slides were immersed in 4°C lysis solution for 60 min. Slides were then immersed in freshly prepared alkaline unwinding solution for 20 min in the dark. Electrophoresis was then performed using the Comet Assay ES unit (Trevigen) as per the kit instructions. Slides were then immersed in DI water two times for 5 min and then 70% ethanol for 5 min. Slides were dried at 37°C for 15-30 min. Slides were stained with 100 µl of diluted SYBR Gold stain for 30 min prior to visualisation. Comet slides were viewed on a Nikon (Melville, NY, USA) TE-2000 U fluorescent microscope and images were captured using a Nikon DS-US digital camera. Individual cells were scored using the CometScore program (TriTek, Sumerduck, VA, USA). Fifty individual cells were scored per treatment from a minimum of eight microscopic fields. The experiment was done in triplicate.
Statistical analysis was performed by the t-test compared to untreated controls.
Results
Characterisation of AgNPs
The AgNPs used in this experiment were characterised using a variety of analytical techniques including DLS, NTA, TEM, UV/Vis spectroscopy and zeta potential analysis. Table 1 provides a summary of the stability and size distribution analyses. With regard to particle size, the z-average obtained from DLS closely matches the mean diameter obtained from NTA and TEM for larger particles (50 and 100 nm), whereas only NTA and TEM agree for the smaller particles. The TEM micrographs shown in Figure 1 are representative of the NP populations measured with ImageJ and offer the most accurate view of the particles' size and agglomeration.
The difference in measured or observed diameters between DLS/ NTA and TEM may be due to several factors. First, DLS and NTA rely on the intensity of light scattered by particles in solution to determine their respective diameters. Since the intensity of scattered lights scales by r 6 (radius raised to the sixth power), larger particles may be weighted significantly more than smaller particles in the calculation of the average diameter. The erroneous biasing of data based on particle size is much more of a problem when using DLS as compared to NTA because scattering intensity is only used indirectly by NTA to find and track particles. Secondly, DLS analysis and NTA yield a calculation of the total hydrodynamic diameter, which includes the actual diameter of the particle in addition to the water shell that surrounds the particle; while TEM can only measure the actual diameter of the metal particle since the water shell is not sufficiently electron dense to provide contrast. Finally, light scattering techniques like DLS and NTA are unable to resolve individual particles that have been agglomerated. The end result is that these techniques observe any agglomerates as single particles resulting in a larger calculated diameter. The higher than expected z-average (DLS) for Batch 1, 10 nm particles are likely due to agglomerates within the solution. The TEM and UV-Vis data confirmed the particles were within specifications, e.g. ~10 nm.
Adding to this evidence, the wavelength of peak light absorption identified with UV/Vis spectroscopy increases with particle size as expected and approximately matches the expected wavelength of peak absorption for each size. Every stock particle solution was found to have minimal size polydispersity through ImageJ analysis of the images acquired through TEM, and no severe agglomeration was observed in any stock solution. Representative TEM micrographs of stock solutions are shown in Figure 1 . Zeta potential values of >|10| mV were obtained for all but the 10 and 20 nm particles in the second batch (Batch 2). While these lower values may be attributed to a slight loss of surface coating or a lower surface charge inherent in their smaller surface area, TEM micrographs show minimal aggregation and similar morphology within each stock solution. These micrographs, in combination with the other characterisation results, provide strong indication that the particles utilised were stable, monodisperse and within their indicated size ranges.
Identification of appropriate AgNP incubation concentrations
Preliminary bacteria cytotoxicity experiments were conducted in order to identify silver concentrations that would be within biologically useful ranges for the genotoxicity studies, which require cell viability for mutant expression (Supplementary Table 1 , available at Mutagenesis Online). Moreover, these results give strain-specific (for S.typhimurium TA100, TA102 and E.coli WP2 uvrA pKM101) confirmation of prior work in the laboratory, which has correlated NP size with antimicrobial activity. An analysis of the survival experiments indicated that AgNO 3 exposures for 1 h at 37°C resulted in a >3 log reduction in survival of all three strains of bacteria at concentrations of 10 ng/ml and higher (Supplementary Table 1 , available at Mutagenesis Online). Similar levels of E.coli survival loss were only achieved by the 10 nm particles, at concentrations at or above 100 ng/ml; 3 log or greater reduction of both Salmonella strains occurred at 500 ng/ml and higher. While the strains differed in their response to the 20 nm particles, at least moderate reduction (>2 log) was observed in all strains above 500 ng/ml. For both the E.coli WP2 uvrA and the Salmonella TA100 strains, the 50 and 100 nm particles were unable to achieve reductions >1.45 log even at the high concentration of 1 µg/ml. The Salmonella TA102 strain was similarly unaffected by the 100 nm particles but was highly sensitive to 50 nm particles at and above 500 ng/ml.
The broadest implication of these experiments is that 10 ng/ ml is a 'safe' operating concentration for experiments that rely on viability because a significant number of all three bacterial strains were able to survive when incubated with NPs of any size at this concentration. While the TA100 bacteria were less sensitive overall to treatment with AgNPs than WP2 uvrA and TA102, all strains exhibited high susceptibility to treatment with AgNO 3 at just 10 ng/ml (Supplementary Table 1 , available at Mutagenesis Online). The results appeared to be independent of the state of the bacterial cell wall since bacteria with the deep rough (rfa) permeability mutation (TA100, TA102) were no more sensitive than bacteria with wildtype cell walls (E.coli strains). The fact that AgNO 3 is more deadly to bacteria than even the smallest AgNPs seems to lend credence to the ion shed theory of silver toxicity, at least for gram-negative bacteria. In addition, our results reinforce evidence suggesting the effective antimicrobial activity of smaller (10 and 20 nm) particles, whereas larger (50 and 100 nm) particles have poorer antimicrobial properties.
Mutagenicity of AgNPs in bacteria
One mechanism of genotoxicity is mutagenicity. The most commonly used test for mutagenicity is the bacterial reverse mutation test (Ames assay), which is easy, cost effective and widely used in the safety analysis of chemical substances (39) . However, this assay has been questioned as a method to assess NP genotoxicity because many NPs tested are negative in the bacterial reverse mutation assays but positive in other genotoxicity assays (40) . There are two commonly proposed reasons for this: (i) lack of NP uptake and (ii) the proposed mechanism of genotoxicity for many NPs that is believed to be oxidative stress (40, 41) . The NPs may have no or limited uptake in bacteria due to limited diffusion and the lack of facilitated uptake such as endocytosis, a function present in mammalian cells (42, 43) . However, there is some evidence that bacterial cells may take up smaller NPs of 20 nm or less in size (40) . However, uptake of NPs may not be necessary to induce a genotoxic effect. Genotoxicity can be caused by the NP interacting directly with DNA or indirectly through the initiation of genotoxic species, such as reactive oxygen species, or through the shedding of ions, which in turn may induce genotoxicity (44) . In order to enhance the likelihood of seeing an indirect genotoxicity response caused by ion shed as well as increase the likelihood of uptake, the bacteria were pre-incubated in a small volume with varied concentrations of AgNPs for 60 min. NPs across a broad size range-10, 20, 50 and 100 nm-as well as a AgNO 3 ion control were tested in S.typhimurium TA98, TA100 and TA102 and E.coli WP2 pKM101 and WP2 uvrA pKM101 bacteria to assess their mutagenicity. The 10 and 20 nm particles are within the range that could potentially be taken up into bacteria according to previous reports (42) . Even with pre-incubation of the AgNPs with the bacteria, mutagenicity was negative across a range of concentrations of AgNPs in all sizes, as well as negative for the AgNO 3 ion control ( Table 2) . The negative results, even with pre-incubation, are consistent with previous studies of AgNPs of 40-60 nm (45) and even for those as small as 5 nm (46) . The strains S.typhimurium TA102 and E.coli WP2 pKM101 and WP2 uvrA pKM101 are known to be sensitive to mutations caused by oxidative processes and were included to assess the proposed mechanism of action of AgNPs as oxidative agents. Even with the inclusion of these strains, no mutagenicity was found in the bacterial experiments performed. The negative result in TA102 was also found previously using 5 nm AgNPs (46) .
One possible explanation for the negative results observed for AgNPs in the bacterial reverse mutation test is that AgNPs may act via genotoxic mechanisms that cannot be detected using bacterial assays. This could include chromosomal DNA damage alterations or chromosome separation aneuploidies rather than mutation (40) . A few mutation assays of AgNPs have also been performed in mammalian cells with sizes from 5 to 113 nm that have all produced negative results (31, 47, 48) . When all of the data for mutagenicity are examined, it supports that AgNPs are not mutagenic (although they may still be genotoxic).
DNA repair in the presence of AgNPs
In addition to the possibility of direct DNA damage by AgNPs, AgNPs may have indirect effects, such as perturbing systems: they may affect the ability of cells to repair DNA damage (44) . As an initial investigation into this possibility, experiments were completed in order to determine if AgNPs are capable of influencing/inhibiting the repair of UV-induced DNA damage in S.typhimurium and E.coli DNA repair competent strains TA102 and WP2 pKM101. Both TA102 and WP2pKM101 are repair competent strains of bacteria that show repair of DNA damage, as measured by mutant yield, over time. Bacteria were exposed to UV light for varied amounts of time and then allowed to repair for 60 min in the presence or absence of AgNPs (Figure 2) . The presence of the AgNPs had no effect on the time-dependent repair of UV-induced DNA damage. AgNO 3 ion controls also did not show an effect on repair of DNA damage in the bacterial strains (data not shown). The experiments reported here were designed to optimise exposure and expand exploration into mechanisms of potential AgNP genotoxic effects, which can occur through both direct and indirect mechanisms, and to facilitate the discussion on the utility of bacterial assays for genotoxicity assessment of nanomaterials.
Uptake analysis with TEM
TEM was utilised to determine how bacterial and mammalian cells interact with AgNPs during incubation. AgNP uptake was investigated in one strain of E.coli (WP2 uvrA), one strain of Salmonella (TA100) and two mammalian cell types (Jurkat and THP-1).
EDS analysis was completed on each of the images to verify the presence of AgNPs within the cells. In each image 'Spectrum 1' corresponds to the background, 'Spectrum 2' corresponds to inside the bacteria and 'Spectrum 3' and 'Spectrum 4' correspond to the observed AgNPs. No uptake was noted for any of the bacterial samples when assessed by TEM. A lack of uptake into bacterial cells has implications related to the acceptance of bacterial systems for genotoxicity assessment of nanomaterials. While an indirect effect of the AgNPs or released silver ions could still be seen without uptake, the direct effect of the AgNPs on the DNA cannot be assessed if there is no contact between the DNA and the AgNPs. As Figure 3 shows, all sizes of AgNPs were readily engulfed by both mammalian cell types. Uptake of AgNPs, ranging in size, by mammalian cells has previously been observed in a variety of human cell lines (36, 37, 49, 50) . In contrast to our study and the other studies cited, a previous study examining 10, 40 and 75 nm AgNPs found no uptake by human lung cells, suggesting that the cell type may be important (30) . It should be noted that the vast majority of the black dots in the images are residual osmium tetroxide imparted to the specimens during tissue preparation, whereas silver is distinguished by the EDS spectra.
The uptake of AgNPs by the two mammalian cell types appeared to be comparable, both in the number of AgNPs uptaken and the location of the AgNPs within the cells. AgNPs were most often observed inside or around the filopodia, cellular membrane and endocytotic vesicles of the Jurkat and THP-1 cells (Figure 3) . Although many NPs were observed to be simply embedded in the cell membrane, the large number of particles sequestered as agglomerates in vesicles indicates that the particles were taken up through an endocytotic mechanism rather than passive diffusion or electrostatic membrane association. While some NPs appeared to be free in the cytoplasm, none were observed inside the nuclei of the mammalian cells and no dramatic intracellular damage was apparent. The results observed in this current study agree with a previous study that found 16 nm AgNPs present in vesicles, yet no particles could be observed in the nuclei or mitochondria of CHO-K1 cells (49) . In contrast to the findings of this current study, some previous studies have demonstrated uptake into the mitochondria and nuclei with 6-20 nm AgNPs in human lung fibroblasts and glioblastoma cell lines (36) and in the nuclei in a human lung cell line (50) . Again, these differences may be a result of the differences in cell type, an area that requires additional research. Particles were often found in agglomerates of 5-10 particles; however, this 'counting' is skewed because smaller secondary particles of silver were often found directly adjacent to their larger 'parent' or primary particles (Figure 3) . It is proposed that AgNPs are internalised and undergo intracellular dissolution, which in turn yields smaller parent AgNPs as well as the formation of secondary silver salt nanocrystals. This in vitro mechanism is supported by other work in the laboratory along with in vivo studies comparing AgNPs to AgNO 3 where oral exposure to the latter resulted in in situ AgNP formation (52) . Due to this leaching/reformation effect, a majority of observed primary and secondary particles were slightly smaller in vitro than the stock particles characterised before incubation.
Cell viability in human T-cell and monocyte cell lines
Mitochondrial activity was assessed as a measure of cell viability in human monocyte and T-cell lines. Both Jurkat and THP-1 cells were exposed to 10, 20, 50 and 100 nm AgNPs and AgNO 3 for 24 h at concentrations from 0 to 50 µg/ml after which time the mitochondrial activity was assessed by the MTS assay. As shown in Figure 4 , mitochondrial activity decreased in a concentration-dependent manner with the AgNO 3 ion controls and with the 10 and 20 nm AgNPs. The strongest toxicity in both cell lines was observed with the AgNO 3 ion control, which is consistent with the literature findings that silver ions are more toxic than AgNPs, especially at low concentrations of AgNPs (52) . The 50 and 100 nm particles were not toxic to either cell line at the concentrations tested. Increased toxicity with decreased AgNP size has previously been demonstrated in both human and murine cells (30, 31) . Toxicity with AgNPs smaller than 50 nm has been previously demonstrated and is consistent with the finding here (32, 49, 53, 54) . Interestingly, although no toxicity was observed with the 50 and 100 nm AgNPs, toxicity has previously been reported for AgNPs within this size range as well in human dermal fibroblasts and A549, a human lung cancer cell line (33, 55) . Of particular interest is the comparison between the findings of this experiment of no toxicity observed with 50 and 100 nm AgNPs, with a previous study of larger AgNPs (90-180 nm) that were cytotoxic in human lymphocytes, collected from whole blood at both 25 and 50 µg/ml (56). The variation or differences in toxicity observed for the 50 and 100 nm AgNPs in this study and other studies mentioned could be due to a number of factors, including cell line versus primary cells and AgNP manufacturing differences, e.g. variation in surface capping chemistry.
While both cell lines demonstrated a dose-dependent cytotoxicity response, the Jurkat cell line was more sensitive to the silver agents than the THP-1 cell line (Figure 4 ). This finding is consistent with previous research that demonstrated variation in sensitivity to AgNPs depending on cell type (31, 33, 36, 37) . A recent study has even suggested that the mechanism of cytotoxicity can be cell-type specific (37) . Another study of particular interest separated the lymphocytes from human blood into T-cell and monocyte fractions and found significant differences in cytotoxicity between these two populations. In particular, there was no cytotoxicity in T-cell populations with AgNPs, and only limited cytotoxicity with silver ions but significant cyotoxicity to monocytes with AgNPs and greatly increased cytotoxicity with silver ions (38) . The particles tested in this study were ~70 nm and coated with PVP, so the lack of toxicity in T cells is consistent with the finding in this experiment for the Jurkat T-cell cell line. However, no toxicity was observed in the THP-1 cell line, in contrast to the findings with isolated human monocytes. There are several possible reasons for the difference in cytotoxic response in lymphocytes from whole blood and the present study. The first is that the particles investigated in this study were coated/stabilised with sodium citrate rather than uncapped or capped with PVP. The surface capping agent may affect the dissolution of silver ions, which is currently believed to be the primary mode of cytotoxicity for AgNPs. In fact, if the cytotoxicity of AgNPs is primarily due to the silver ions, then any physico-chemical parameters that affect ion release, e.g. size, shape, surface coating, would also directly impact cytotoxicity. Secondly, it is possible that primary human lymphocytes are more sensitive than human lymphocyte cell lines, an important question that has yet to be addressed.
Chromosomal damaging effects of AgNPs in human T-cell and monocyte cell lines
AgNPs were assessed for the ability to act as clastogens (breakers of chromosomes) in human T-cell and human monocyte cell lines. Both Jurkat and THP-1 cells were exposed to 10, 20, 50 and 100 nm AgNPs and AgNO 3 for 24 h at concentrations from 0 to 50 µg/ml, after which time the formation of micronuclei (a measure of chromosomal fragments) was assessed by the flow cytometry-based micronucleus assay. Samples were first assessed for cytotoxicity using flow cytometry; samples with >50% non-apoptotic or necrotic cells were assessed for micronucleus formation. Ten thousand healthy nuclei were assessed per treatment for an increase in micronucleus formation following exposure to AgNO 3 or AgNPs. As seen in Figure 5 , all sizes of AgNPs produced a statistically significant and dosedependent increase in micronuclei. However, it is clear from the data that micronucleus induction was strongly size-dependent, with more micronuclei being observed as NP size decreased. The strength of the response can be seen in the fold increase over the control. In the THP-1 cells, the 50 and 100 nm AgNP exposures only produced effects of 2-fold increase and in the Jurkat cells, only the top dose of 50 and 100 nm AgNPs produced a 2-fold increase over control. In comparison, the Mitomycin C positive control produced a ~10-fold increase in micronuclei. The induction of micronuclei was much stronger with the 20 nm particles, with a dose as low as 15 µg/ml in Jurkat and 20 µg/ml in the THP-1 cells producing a >3-fold increase in micronuclei. The 10 nm AgNPs produced the strongest response of all the NP-treated groups, with a 3-fold increase achieved at 10 µg/ml in Jurkat cells and 15 µg/ml in THP-1 cells. The trends in micronucleus induction follow the trends in cytotoxicity, with smaller particles producing stronger responses and the Jurkat cells showing greater sensitivity to AgNP exposure than the THP-1 cells. Differences in micronucleus induction between different cell types have previously been observed with starch-coated AgNPs (36) .
AgNO 3 was also tested in this study as an 'ion control', e.g. to determine the effect that pure silver ions had on micronucleus induction. As shown in Figure 5 , AgNO 3 produced the strongest induction of micronuclei for both cell types. Silver ions have previously been shown to induce micronuclei and have been shown to have a stronger effect than AgNPs (49) . To our knowledge, no previous study has examined the effect of AgNP size on micronucleus formation; however, a number of previous studies have found that AgNPs of sizes ranging from 5 to 60 nm do induce micronuclei (36, 45, 46, 49, 50, 57) . A single study has found negative results for micronucleus formation using AgNPs; however, this study used PVP-coated AgNPs and postulated that this negative result could be due to the presence of the coating (54) . The results of the work presented here indicate that micronucleus induction is correlated with the dissolution or exposure of the cells to silver ions (Ag + ).
DNA damage caused by exposure of human T-cells and monocytes to AgNPs
In addition to chromosomal alterations or mutagenic activity, exposure to AgNPs could lead to other types of DNA damage. To assess this possibility, both Jurkat and THP-1 cells were exposed to 10, 20, 50 and 100 nm AgNP and AgNO 3 for 24 h at concentrations from 0 to 50 µg/ml, after which time DNA damage was assessed by the single cell electrophoresis (Comet) assay. As seen in Figure 6 , DNA damage was detected following exposure to the 10 and 20 nm AgNPs but not by exposure to the 50 or 100 nm AgNPs. Exposure to silver ions (AgNO 3 ) produced a stronger response than any particle size in both cell lines, suggesting a major effect of silver ions in this DNA damage response. The results agree with previous research that has shown that AgNPs exposure can result in DNA damage in a wide variety of mammalian cell lines and with a wide variety of sizes of AgNPs ranging from 5 to 100 nm (30, 32, 33, 36, 37, 45, 47, 50, 53, 54, (56) (57) (58) .
Discussion
Experiments were completed to gain a better understanding of the genotoxicity of AgNPs, specifically the mechanism of genotoxicity and how genotoxicity can be related to the physico-chemical properties (size) of the AgNP along with cellular uptake. The genotoxicity of four sizes of AgNPs was assessed for three potential mechanisms: mutagenicity, clastogenicity and DNA strand breaks. Mutagenicity was assessed in five bacterial samples, including TA102 that is sensitive to oxidative DNA damage. AgNPs of all sizes, along with AgNO 3 , were negative for mutagenicity in bacteria, which could be due to a lack of uptake of the particles into the bacteria. The lack of uptake of AgNPs into the bacteria cells was confirmed by TEM and corresponding EDS analysis. This work agrees with previous research in the field, suggesting that NPs >10 nm are unable to be taken up by bacteria due to lack of active uptake mechanisms (42, 43, 59) . However, it is well accepted that silver ions are able to penetrate bacteria, a finding corroborated by the fact that a primary mechanism of silver's antimicrobial activity is based on interfering with key internal bacterial components (3-9).
The results of the testing with AgNO 3 suggest that silver ions are non-mutagenic. This finding agrees with previous studies using mammalian studies that have shown that AgNPs, or silver ions, are non-mutagenic. Yet, only a limited number of studies have investigated the mutagenicity of AgNPs in mammalian cell systems (60, 61) . Further research in the field is clearly needed to understand the mutagenic potential of both AgNPs and silver ions.
Chromosomal damaging effects of AgNPs were assessed using flow cytometry and the micronucleus assay. It was found that AgNPs (of all sizes) induced the formation of micronuclei in both cell types (Jurkat and THP-1) and that micronucleus induction was strongly correlated to the size of the NP, with smaller NPs resulting in an increase in micronuclei prevalence. Furthermore, it was found that AgNO 3 produced the greatest amount of micronuclei, indicating that silver ions are more genotoxic when compared to AgNPs at the same concentrations. The observation that smaller AgNPs produced a greater response than larger NPs along with the observation that AgNO 3 produced the highest response indicates that chromosomal damaging effects of AgNPs may be strongly correlated to silver ion release. Previous research has shown that ion release can be closely related to size of the particle, with greater ion release observed with small particles. The enhanced ion release of smaller particles is theorised to be due to the increased surface area in addition to enhanced dissolution of ions due to the increased curvature at smaller sizes (24, 26, 27, 62) .
The ability of AgNPs to induce DNA damage intermediates (strand breaks) was assessed using the Comet assay (in vitro). Similar to the chromosomal damaging results, it was discovered that DNA strand break formation was strongly dependent on AgNP size, with smaller NPs inducing more damage than larger particles. Furthermore, it was found that AgNO 3 induced more DNA damage than any of the AgNPs at the same concentrations. The results of the experiment indicate that, similar to chromosomal damaging effects, DNA strand break formation is likely correlated to silver ion release.
TEM analysis confirmed that AgNPs were endocytosed by both mammalian cell lines. All particles confirmed within the mammalian cells were appeared to be contained within intracellular vesicles, most likely endosomes, and no particles were ever observed within the nucleus. Since DNA is exposed during cell division, the fact that no particles seemed to be able to penetrate the nucleus does not invalidate the theory that AgNPs can induce DNA damage through direct interaction, since the nuclear membrane is dissolved and DNA is exposed during cell replication. Yet, since most particles were observed within intracellular vesicles and not free in the cytoplasm, it is unlikely that there was any type of direct interaction between the NPs and the DNA, even during cell division. The results strongly suggest that the genotoxic mechanism of AgNPs is either due to soluble ions that evolve from the particles or indirect effects of the particles or ions, such as the generation of reactive oxygen species. The correlation between particle size and clastogenicity/DNA damage in mammalian cells combined with the fact that AgNO 3 induced more clastogenicity/DNA damage than the respective NPs at the same concentrations strongly indicates that silver ions are a primary cause of the observed genotoxicity.
The results of this research have implications both for understanding the genotoxicity of AgNPs and for the development and application of proper techniques/protocols to assess genotoxicity. Currently, there is much debate revolving around the use of bacterial assays to assess genotoxicity due to the apparent inability of bacteria to uptake NPs. The results of this work suggest that there is little to no direct interaction between AgNPs and DNA, indicating that silver ions are the primary, and perhaps only, cause of genotoxicity (clastogenicity and DNA damage). If silver ions are indeed the primary cause of genotoxicity and no interaction between the AgNPs and DNA occurs, bacterial assays may be sufficient to assess genotoxicity for AgNPs since it is well-known silver ions readily penetrate bacterial cells. If the bacterial assays are adequate, then the negative results seen to date suggest that AgNPs are not mutagenic. On the other hand, any physico-chemical parameter or cellular interaction that affects silver ion release from NPs will also affect genotoxicity. It is reasonable to conjecture that uptake of AgNPs would lead to enhanced silver ion dissolution, either due to the proximity of the NPs to the DNA or the acidic environment of the vesicle to which the particles are compartmentalised. Currently, it remains unclear if the bacterial assays are an adequate test for mutation in the presence of AgNPs and further testing that directly compares mammalian mutation assays with bacterial assays using identical, well-characterised particles is necessary.
Although this research has provided insights into the primary causes of AgNP genotoxicity, the complete mechanism is likely quite complex and will require further experimental studies. Areas of interest for future studies include investigating how specific physicochemical parameters of AgNPs affect ion release, how physiological environment can affect ion release and the specific mechanism by which silver ions induce genotoxicity. In vivo experiments, e.g. animal experiments, will also be vital in order to correlate in vitro observations to clinically significant effects. Due to the increased prevalence of AgNPs in consumer and medical products, it is imperative that the scientific community develop a clear understanding of how AgNPs induce genotoxicity and elucidate the primary causes of this toxicity.
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